ArticleJournal of cancer research and clinical oncology2021

Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines.

Karen Bräutigam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.